Lipomed GmbH
7 products tracked · names used in filings: Lipomed GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Qaialdo spironolactone | Authorised | 2023-05-26 |
| 🇪🇺 | Thalidomide Lipomed thalidomide | Authorised | 2022-09-19 |
| 🇪🇺 | Jayempi azathioprine | Authorised | 2021-06-21 |
| 🇪🇺 | Xromi hydroxycarbamide | Authorised | 2019-07-01 |
| 🇪🇺 | Deferiprone Lipomed deferiprone | Authorised | 2018-09-19 |
| 🇪🇺 | Xaluprine (previously Mercaptopurine Nova Laboratories) mercaptopurine | Authorised | 2012-03-09 |
| 🇪🇺 | Litak cladribine | Authorised | 2004-04-14 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.